Company Filing History:

26 out of 200

Pharmacia Corporation

patents

14 out of 1,323

G.d. Searle & Company

Pharmacia Corporation Global Patent Department

patent

Years Active: 2002-2010

Loading Chart...

49 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7795271 - Substituted pyrimidinones (2010-09-14),

2. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),

3. 7629363 - Diaryl substituted pyridinones (2009-12-08),

4. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),

5. 7196118 - Amidino compounds useful as nitric oxide synthase inhibitors (2007-03-27),

6. 7183287 - Substituted pyrimidinones (2007-02-27),

7. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),

8. 7102013 - Methods of making amidino compounds useful as nitric oxide synthase inhibitors (2006-09-05),

9. 7067540 - Substituted pyridinones (2006-06-27),

10. 7005450 - 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors (2006-02-28),

11. 6924313 - Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity (2005-08-02),

12. 6914158 - Amidino compounds useful as nitric oxide synthase inhibitors (2005-07-05),

13. 6861561 - Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity (2005-03-01),

14. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

15. 6787570 - Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-09-07),

Title: Richard C Durley - Pioneering Innovator in Pharmaceutical Chemistry

Introduction

Richard C Durley, based in Chesterfield, Missouri, is a notable inventor with an impressive portfolio of 49 patents. His work primarily focuses on pharmaceutical chemistry, developing compounds that address critical health issues related to kinase activity and cholesterol transfer. Durley's contributions to the field have significantly impacted the development of therapeutic compounds.

Latest Patents

Among his latest innovations, Durley has developed compounds for treating diseases linked to unregulated p38 MAP Kinase and TNF activity. His patent on substituted pyrimidinones features pharmaceutically acceptable salts intended to ameliorate conditions exacerbated by these factors. Additionally, he has patented (R)-chiral halogenated substituted fused heterocyclic amino compounds that inhibit cholesterol ester transfer protein activity, with implications for addressing atherosclerosis and coronary artery diseases. His methodologies for producing these compounds are characterized by high yield and stereoselectivity, underscoring his ability to improve pharmaceutical processes.

Career Highlights

Throughout his career, Richard has made significant strides in the pharmaceutical sector, contributing to the work of leading companies such as Pharmacia Corporation and G.D. Searle & Company. His expertise in developing innovative therapeutic solutions has been a driving force in numerous successful projects aimed at improving patient outcomes.

Collaborations

Durley has worked alongside esteemed colleagues, including Brian S Hickory and James A Sikorski. These collaborations have fostered an environment of innovation, enabling the development of groundbreaking solutions in pharmaceutical chemistry and beyond.

Conclusion

Richard C Durley's dedication to advancing pharmaceutical science through his extensive patent work highlights his status as a leading inventor in his field. The compounds and methods he has developed serve as a testament to the potential of innovative thinking in addressing complex health challenges. His contributions continue to inspire future generations of scientists and inventors striving to improve global health through innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.